Cargando…
Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical ca...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491257/ https://www.ncbi.nlm.nih.gov/pubmed/28662160 http://dx.doi.org/10.1371/journal.pone.0180618 |
_version_ | 1783247112103788544 |
---|---|
author | Zhang, Liran Xie, Fengxiang Wang, Xinguo Peng, Dezhi Bi, Chunrui Jiang, Lingbo Zhao, Dongman Tian, Xinxin Qi, Debo |
author_facet | Zhang, Liran Xie, Fengxiang Wang, Xinguo Peng, Dezhi Bi, Chunrui Jiang, Lingbo Zhao, Dongman Tian, Xinxin Qi, Debo |
author_sort | Zhang, Liran |
collection | PubMed |
description | BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. METHODS: A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. RESULTS: A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). CONCLUSIONS: The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China. |
format | Online Article Text |
id | pubmed-5491257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54912572017-07-18 Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China Zhang, Liran Xie, Fengxiang Wang, Xinguo Peng, Dezhi Bi, Chunrui Jiang, Lingbo Zhao, Dongman Tian, Xinxin Qi, Debo PLoS One Research Article BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. METHODS: A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. RESULTS: A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). CONCLUSIONS: The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China. Public Library of Science 2017-06-29 /pmc/articles/PMC5491257/ /pubmed/28662160 http://dx.doi.org/10.1371/journal.pone.0180618 Text en © 2017 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zhang, Liran Xie, Fengxiang Wang, Xinguo Peng, Dezhi Bi, Chunrui Jiang, Lingbo Zhao, Dongman Tian, Xinxin Qi, Debo Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title | Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title_full | Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title_fullStr | Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title_full_unstemmed | Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title_short | Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China |
title_sort | previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in shandong province, china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491257/ https://www.ncbi.nlm.nih.gov/pubmed/28662160 http://dx.doi.org/10.1371/journal.pone.0180618 |
work_keys_str_mv | AT zhangliran previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT xiefengxiang previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT wangxinguo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT pengdezhi previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT bichunrui previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT jianglingbo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT zhaodongman previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT tianxinxin previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina AT qidebo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina |